Gary R. Point
Publications by Year
Research Areas
CAR-T cell therapy research, Phagocytosis and Immune Regulation, Immunotherapy and Immune Responses, Renal Transplantation Outcomes and Treatments, Immune Cell Function and Interaction
Most-Cited Works
- → Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA+ Liver Metastases(2015)376 cited
- → Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T(2015)220 cited
- → Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery(2016)169 cited
- → PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor(2019)157 cited
- → HIV-1 DNA Levels in Peripheral Blood Mononuclear Cells and Cannabis Use are Associated With Intermittent HIV Shedding in Semen of Men Who Have Sex With Men on Successful Antiretroviral Regimens(2014)42 cited
- → Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells(2014)16 cited
- → Novel in vivo and ex vivo hybrid in vivo imaging system (IVIS) imaging offers a convenient and precise way to measure the glomerular filtration rate in conscious mice(2021)8 cited
- → Supplemental Figure 3 from Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor–Modified T-cell Therapy for CEA<sup>+</sup> Liver Metastases(2023)
- → Anti-CEA chimeric antigen receptor T cells in combination with suppressor cell targeting for the treatment of colorectal cancer peritoneal metastases (VAC7P.1043)(2015)
- → Abstract 2301: Intraperitoneal CAR-T infusion results in durable protection against peritoneal metastases and control of systemic tumor growth(2016)